DK0895782T3 - Farmaceutiske præparater af cilansetron stabiliseret mod racemisering - Google Patents

Farmaceutiske præparater af cilansetron stabiliseret mod racemisering

Info

Publication number
DK0895782T3
DK0895782T3 DK98113643T DK98113643T DK0895782T3 DK 0895782 T3 DK0895782 T3 DK 0895782T3 DK 98113643 T DK98113643 T DK 98113643T DK 98113643 T DK98113643 T DK 98113643T DK 0895782 T3 DK0895782 T3 DK 0895782T3
Authority
DK
Denmark
Prior art keywords
cilansetron
pharmaceuticals
stabilized against
against racemization
racemization
Prior art date
Application number
DK98113643T
Other languages
Danish (da)
English (en)
Inventor
Ingo Bonnacker
Gerhard Kristen
Hartmut Koehn
Christine Reichel
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Application granted granted Critical
Publication of DK0895782T3 publication Critical patent/DK0895782T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK98113643T 1997-08-01 1998-07-22 Farmaceutiske præparater af cilansetron stabiliseret mod racemisering DK0895782T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19733271 1997-08-01
EP98113643A EP0895782B1 (de) 1997-08-01 1998-07-22 "Gegen Racemisierung stabilisierte pharmazeutische Zubereitungen von Cilansetron"

Publications (1)

Publication Number Publication Date
DK0895782T3 true DK0895782T3 (da) 2005-01-03

Family

ID=7837672

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98113643T DK0895782T3 (da) 1997-08-01 1998-07-22 Farmaceutiske præparater af cilansetron stabiliseret mod racemisering

Country Status (29)

Country Link
US (1) US5977127A (tr)
EP (1) EP0895782B1 (tr)
JP (1) JP4324260B2 (tr)
KR (1) KR100515201B1 (tr)
CN (1) CN1117565C (tr)
AR (1) AR010178A1 (tr)
AT (1) ATE283706T1 (tr)
AU (1) AU743043B2 (tr)
BR (1) BR9803730A (tr)
CA (1) CA2244389C (tr)
CZ (1) CZ295072B6 (tr)
DE (2) DE19813661A1 (tr)
DK (1) DK0895782T3 (tr)
DZ (1) DZ2560A1 (tr)
ES (1) ES2234051T3 (tr)
HK (1) HK1017611A1 (tr)
HU (1) HUP9801712A3 (tr)
ID (1) ID20685A (tr)
IL (1) IL125403A (tr)
NO (1) NO323229B1 (tr)
NZ (1) NZ331083A (tr)
PL (1) PL191767B1 (tr)
PT (1) PT895782E (tr)
RU (1) RU2199318C2 (tr)
SK (1) SK284916B6 (tr)
TR (1) TR199801432A3 (tr)
TW (1) TW509570B (tr)
UA (1) UA62924C2 (tr)
ZA (1) ZA986715B (tr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7452545B2 (en) * 2001-11-13 2008-11-18 Yu Ruey J Oligosaccharide aldonic acids and their topical use
CA2439097C (en) * 2001-03-26 2010-10-12 Novartis Ag Pharmaceutical compositions
US20040048874A1 (en) * 2001-05-22 2004-03-11 Bardsley Hazel Judith New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
GB0216027D0 (en) * 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
KR20050094843A (ko) * 2003-01-13 2005-09-28 다이노젠 파마세우티컬스, 인코포레이티드 욕지기, 구토, 구역질 또는 이들의 조합을 치료하는 방법
AU2004204825B2 (en) * 2003-01-13 2007-07-19 Dynogen Pharmaceuticals, Inc. Method of treating functional bowel disorders
ATE365554T1 (de) * 2003-04-04 2007-07-15 Dynogen Pharmaceuticals Inc Methode zur behandlung von erkrankungen der unteren harnwege
US7820690B2 (en) * 2004-03-19 2010-10-26 Solvay Pharmaceuticals Gmbh Method of treating or inhibiting a non-digestive tract derived abdominal disorder associated with pain using a 5-HT, receptor antagonist
US20060293309A1 (en) * 2005-03-28 2006-12-28 Dynogen Pharmaceuticals, Inc. Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitors
JPWO2010018866A1 (ja) 2008-08-14 2012-01-26 杏林製薬株式会社 安定化された医薬組成物
EP4062973A4 (en) 2019-11-20 2023-11-29 Shionogi & Co., Ltd SOLID FORMULATION CONTAINING 6,7-UNSATURATED-7-CARBAMOYL MORPHINAND DERIVATIVE

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0297651B1 (en) * 1987-06-29 1993-11-03 Duphar International Research B.V Anellated indole derivatives
DE4238553A1 (de) * 1992-11-14 1994-05-19 Kali Chemie Pharma Gmbh Neue Imidazol-1-yl-Verbindungen enthaltende Arzneimittel
AU702594B2 (en) * 1995-10-13 1999-02-25 Duphar International Research B.V. Process for the preparation of enantiomerically pure imidazolyl compounds

Also Published As

Publication number Publication date
PL327786A1 (en) 1999-02-15
AU743043B2 (en) 2002-01-17
PT895782E (pt) 2005-02-28
CN1117565C (zh) 2003-08-13
DE19813661A1 (de) 1999-02-04
TR199801432A2 (tr) 1999-02-22
JPH1192369A (ja) 1999-04-06
ES2234051T3 (es) 2005-06-16
NO323229B1 (no) 2007-02-05
HUP9801712A3 (en) 2001-08-28
NZ331083A (en) 2000-01-28
HU9801712D0 (en) 1998-09-28
CZ236798A3 (cs) 1999-02-17
HUP9801712A2 (hu) 1999-04-28
NO983540L (no) 1999-02-02
CA2244389C (en) 2008-01-15
TW509570B (en) 2002-11-11
CN1207292A (zh) 1999-02-10
AU7863098A (en) 1999-02-11
DE59812317D1 (de) 2005-01-05
IL125403A (en) 2001-11-25
ID20685A (id) 1999-02-18
KR100515201B1 (ko) 2005-12-09
ZA986715B (en) 1999-02-04
ATE283706T1 (de) 2004-12-15
EP0895782B1 (de) 2004-12-01
NO983540D0 (no) 1998-07-31
SK100998A3 (en) 1999-02-11
RU2199318C2 (ru) 2003-02-27
EP0895782A2 (de) 1999-02-10
SK284916B6 (sk) 2006-02-02
BR9803730A (pt) 2000-03-28
DZ2560A1 (fr) 2003-02-15
US5977127A (en) 1999-11-02
JP4324260B2 (ja) 2009-09-02
EP0895782A3 (de) 2001-01-31
IL125403A0 (en) 1999-03-12
AR010178A1 (es) 2000-05-17
CA2244389A1 (en) 1999-02-01
CZ295072B6 (cs) 2005-05-18
PL191767B1 (pl) 2006-06-30
TR199801432A3 (tr) 1999-02-22
KR19990023194A (ko) 1999-03-25
UA62924C2 (en) 2004-01-15
HK1017611A1 (en) 1999-11-26

Similar Documents

Publication Publication Date Title
PT996622E (pt) Novos compostos heterociclicos espiroazabiciclicos
DK1027332T3 (da) Hidtil ukendte lactametalloproteaseinhibitorer
NO992417D0 (no) Tannb°rste
DE69813616D1 (de) Cyclohexencarboxylate als inhibitoren der neuraminidase
IS5354A (is) Ný efnasambönd
BR9608155A (pt) Amino fenil uracilas substituídas
DE69810721D1 (de) Taktsteuerung
DE59810818D1 (de) Fügeverbindung
ID24571A (id) Senyawa tienopirimidin
IS2230B (is) Aukinn stöðugleiki lausna til inndælingar
DE59708269D1 (de) Cyclische adhäsionsinhibitoren
DK0895782T3 (da) Farmaceutiske præparater af cilansetron stabiliseret mod racemisering
DE69811367D1 (de) Cis-substituierte fluoromethylpyrrolidin-derivate
NO995653L (no) Cis-substituerte aminocykloalkyl-pyrrolidin-derivater
DK0864564T3 (da) Særlig fremgangsmåde til fremstillingen af alfa-bromlactamderivater
ID20635A (id) Senyawa metalosen
DE69801549D1 (de) Schwalbenschwanzförmige Flüssigkristallverbindung
DE59811182D1 (de) Heterocyclische Verbindungen
DK1051156T3 (da) Farmaceutiske præparater
KR970063640U (ko) 시계용 문자판
KR970052584U (ko) 시계
BR9704743A (pt) Novo composto
ID19787A (id) Senyawa 25-hidroksi-16-ena-26,27-bishomo-kolekalsiferol
UA2260S (uk) Бочка
SE9702378D0 (sv) New compounds